Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Protein engineering responses to the COVID-19 pandemic
Ching‐Lin Hsieh, Jason S. McLellan
Current Opinion in Structural Biology (2022) Vol. 74, pp. 102385-102385
Open Access | Times Cited: 18

Showing 18 citing articles:

Opportunities and challenges in design and optimization of protein function
Dina Listov, Casper A. Goverde, Bruno E. Correia, et al.
Nature Reviews Molecular Cell Biology (2024) Vol. 25, Iss. 8, pp. 639-653
Closed Access | Times Cited: 35
Computational Methods in Immunology and Vaccinology: Design and Development of Antibodies and Immunogens
Federica Guarra, Giorgio Colombo
Journal of Chemical Theory and Computation (2023) Vol. 19, Iss. 16, pp. 5315-5333
Open Access | Times Cited: 28
Prefusion-stabilized SARS-CoV-2 S2-only antigen provides protection against SARS-CoV-2 challenge
Ching‐Lin Hsieh, Sarah R. Leist, Emily Happy Miller, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Intranasal SARS-CoV-2 RBD decorated nanoparticle vaccine enhances viral clearance in the Syrian hamster model
Devanshi R. Patel, Allen M. Minns, Derek G. Sim, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 3
Open Access | Times Cited: 5
Simulation-driven design of stabilized SARS-CoV-2 spike S2 immunogens
Xandra Nuqui, Lorenzo Casalino, Ling Zhou, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Towards developing multistrain PEDV vaccines: Integrating basic concepts and SARS-CoV-2 pan-sarbecovirus strategies
Mario Fragoso-Saavedra, Qiang Liu
Virology (2025) Vol. 604, pp. 110412-110412
Closed Access
Computational design of vaccine immunogens
Karla M. Castro, Andreas Scheck, Shuhao Xiao, et al.
Current Opinion in Biotechnology (2022) Vol. 78, pp. 102821-102821
Open Access | Times Cited: 20
Surface-modified measles vaccines encoding oligomeric, prefusion-stabilized SARS-CoV-2 spike glycoproteins boost neutralizing antibody responses to Omicron and historical variants, independent of measles seropositivity
Miguel Ángel Muñoz-Alía, Rebecca A. Nace, Baskar Balakrishnan, et al.
mBio (2024) Vol. 15, Iss. 2
Open Access | Times Cited: 1
Development of multidose thermotolerant formulations of a vector-based Covid-19 vaccine candidate, NDV-HXP-S in different product formats: Stability and preservative efficacy study
Anan Bzami, Changcheng Zhu, Marcus Estrada, et al.
Vaccine X (2024) Vol. 20, pp. 100535-100535
Open Access | Times Cited: 1
Multistage protective anti-CelTOS monoclonal antibodies with cross-species sterile protection against malaria
Wai Kwan Tang, Nichole D. Salinas, Surendra Kumar Kolli, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Engineering a cleaved, prefusion-stabilized influenza B virus hemagglutinin by identification and locking of all six pH-switches
Jarek Juraszek, Fin Milder, Xiaodi Yu, et al.
PNAS Nexus (2024) Vol. 3, Iss. 10
Open Access | Times Cited: 1
Surface-modified measles vaccines encoding oligomeric, fusion-stabilized SARS-CoV-2 spike glycoproteins bypass measles seropositivity, boosting neutralizing antibody responses to omicron and historical variants
Miguel Ángel Muñoz-Alía, Rebecca A. Nace, Baskar Balakrishnan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 6
Protein-Based Nanocarriers and Nanotherapeutics for Infection and Inflammation
Nupur Nagar, Goutami Naidu, Amit Mishra, et al.
Journal of Pharmacology and Experimental Therapeutics (2023) Vol. 388, Iss. 1, pp. 91-109
Open Access | Times Cited: 3
Simulation-Driven Design of Stabilized SARS-CoV-2 Spike S2 Immunogens
Xandra Nuqui, Lorenzo Casalino, Ling Zhou, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Protein engineering for natural product biosynthesis: expanding diversity for therapeutic applications
Sarah Otun, Jordy Alexis Lerma-Escalera, Khayalethu Ntushelo, et al.
Journal of Bio-X Research (2023) Vol. 06, Iss. 02, pp. 49-60
Open Access | Times Cited: 2
Mechanistic insights into structure-based design of a Lyme disease subunit vaccine
Kalvis Brangulis, Jill Malfetano, Ashley L. Marcinkiewicz, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Editorial: Intersection of biophysical and structural approaches in vaccine design
Christopher P. Ptak, Ching‐Lin Hsieh, James A. Garnett, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access
Intranasal SARS-CoV-2 RBD decorated nanoparticle vaccine enhances viral clearance in the Syrian hamster model
DR Patel, AM Minns, DG Sim, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Page 1

Scroll to top